Hematology NewsFDA panel not ready to recommend quizartinib approval for FLT3-ITD+ AMLMay 14, 2019AMLLeukemia, Myelodysplasia, Transplantation
Hematology NewsPeanut contamination risk prompts Promacta recallMay 14, 2019Bleeding DisordersAnemiaThrombosis
Oncology PracticeFDA issues final guidance on seeking licensure for interchangeable biologicsMay 13, 2019Business of MedicinePractice Management
Hematology NewsFDA approves ivosidenib frontline for certain AML patientsMay 3, 2019AMLLeukemia, Myelodysplasia, TransplantationRare Diseases
Hematology NewsCDC warns against misuse of opioid-prescribing guidelineApril 24, 2019AnemiaPatient & Survivor CareOpioid Resource Center
Hematology NewsCDC clarifies opioid prescribing guidelines in cancer, sickle cell diseaseApril 15, 2019Patient & Survivor CareOpioid Resource CenterAnemiaBusiness of MedicinePractice Management
Oncology PracticeFDA approves pembrolizumab for first-line stage III NSCLCApril 12, 2019Lung CancerImmuno-oncology
Oncology PracticeFDA approves palbociclib for men with HR+/HER2- advanced breast cancerApril 4, 2019Breast Cancer
Hematology NewsPowerful breast-implant testimony constrained by limited evidenceApril 4, 2019Aggressive LymphomasLymphoma & Plasma Cell Disorders
Hematology NewsFDA panel calls for changes to breast implant rupture screeningMarch 27, 2019Aggressive LymphomasLymphoma & Plasma Cell Disorders
Hematology NewsFDA examines changing donation policies for men who have sex with menMarch 21, 2019Transfusion Medicine
Hematology NewsPriority review granted to lenalidomide for FL, MZLMarch 2, 2019B Cell LymphomaLymphoma & Plasma Cell DisordersAggressive Lymphomas
Hematology NewsSelinexor hits FDA stumbling blockFebruary 26, 2019Multiple MyelomaLymphoma & Plasma Cell Disorders
